CJC-1295 + Ipamorelin
GHRH-analogue + GH-secretagogue peptide combination, lyophilised. For research use only.
Key facts
- Compound:
- CJC-1295 + Ipamorelin
- Purity:
- ≥99%, verified by HPLC
- Identity confirmed by:
- LC-MS, independent third-party lab
- Certificate of analysis:
- available on request, verifiable by lot number
- Ships from:
- Vancouver, BC — typically 2–5 business days, tracked and insured, no customs
- Intended use:
- in vitro laboratory research only — not for human or veterinary consumption
Page last updated
This is a two-peptide combination of CJC-1295 (a GHRH analogue) and ipamorelin (a GH secretagogue).
CJC-1295 + Ipamorelin, supplied to Canadian researchers by Popular Peptides. One 10 mg vial, ≥99% purity. Independently tested by HPLC and LC-MS; the batch-specific Certificate of Analysis is available on request. The lot number on the vial can be checked at popularpeptides.ca/verify. Ships tracked and insured from Vancouver in 2 to 5 business days, with no customs step and no brokerage fee.
Supplied lyophilised for in vitro laboratory research use only; not intended for human or veterinary use.
Primary literature
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults — Journal of Clinical Endocrinology & Metabolism, 2006
Teichman et al. Randomised controlled trial of the CJC-1295 component in healthy adults.
- Ipamorelin, the first selective growth hormone secretagogue — European Journal of Endocrinology, 1998
Raun et al. The paper that first characterised ipamorelin and its selectivity for GH release over ACTH and cortisol.
Cited for research context. A citation is not a claim that this compound is safe, effective, or approved for any use.
⚠️ Research Use Only. This compound is intended for in vitro research and laboratory use only. Not for human or veterinary consumption.
CJC+Ipa — compound background
Combination — GHRH(1-29) analogue plus selective ghrelin-receptor agonist
This is a two-compound blend studied for complementary mechanisms rather than a single molecule. CJC-1295 is a modified GHRH(1-29) fragment with four amino-acid substitutions that resist enzymatic degradation. Ipamorelin is a pentapeptide ghrelin-receptor agonist notable for its selectivity — it was specifically developed to stimulate GH release without the cortisol and prolactin effects of earlier secretagogues like GHRP-6.
Solubility & reconstitution
Both components are water-soluble and dissolve together in a single diluent volume without difficulty. Because this is a blend, the reconstituted concentration figure refers to combined peptide mass unless the label specifies a per-component split — worth confirming before calculating.
Storage
Sealed at -20 °C. Co-lyophilized blends are stored on the terms of their least stable component. Refrigerate at 2–8 °C, protected from light. Ipamorelin contains a tryptophan-like aromatic residue set that warrants light protection.
Commonly worked with for 2–3 weeks at 2–8 °C — governed by the shorter-lived component.
Stability
The key handling implication of a blend is that its stability window is not an average — it is the minimum across components. Apply the more conservative of the two profiles.
Reading the Certificate of Analysis
A blend COA should resolve and report BOTH components, ideally with a ratio. A single purity figure for a two-component product is uninformative — it cannot tell you whether the ratio is correct. Look for two identified peaks on the chromatogram and two confirmed molecular ions.
Background and handling information is educational, for in-vitro laboratory research use only — not medical advice, dosing, or usage guidance, and not a description of use in humans or animals.
How much does CJC-1295 + Ipamorelin cost in Canada?+
Where can I buy CJC-1295 + Ipamorelin in Canada?+
What sizes of CJC-1295 + Ipamorelin are available?+
Is CJC-1295 + Ipamorelin third-party tested?+
What purity is CJC-1295 + Ipamorelin?+
Is CJC-1295 + Ipamorelin intended for human or veterinary use?+
Do you ship CJC-1295 + Ipamorelin across Canada?+
How should CJC-1295 + Ipamorelin be stored?+
CJC+Ipa laboratory reference
CJC-1295 + Ipamorelin is combination — ghrh(1-29) analogue plus selective ghrelin-receptor agonist. Handling requirements follow from that chemistry rather than from generic peptide guidance — the pages below cover each aspect specifically for this compound.
Lyophilized and reconstituted storage conditions, plus the practical working window.
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
Which solvents work, why, and what abnormal dissolution behaviour indicates.
The specific chemical routes by which this molecule breaks down, and how to limit each.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
Questions specific to this compound — structure, chemistry, and common misconceptions.
CJC+Ipa compared with
Reference content is educational laboratory-handling information for in-vitro research use only — not medical advice, not usage guidance, and not a protocol.